Patti R, Angileri M, Migliore G, Sparancello M, Termine S, Crivello F, Gioè F P, Di Vita G
Division of General Surgery, Department of Surgical and Oncologic Science, University of Palermo, Palermo, Italy.
G Chir. 2006 Aug-Sep;27(8-9):331-4.
Pilonidal sinus (PS) disease of the sacrococcigeal region is an acquired condition resulting from penetration of shed hair shafts through the skin. Different types of operations have been described in the letterature. More recently fibrin glue has been used with succesfull. Aim of this study was to assess the effectiveness of fibrin glue for the treatment of pilonidal sinus.
Eight patients age ranged 21,8 +/- 6,5 affected by PS disease of sacrococcigeal region were included in this study. All patients undergoing surgical operation under local anaesthesia. Following administration of 1% methylene blue through the main opening, a small vertical elliptical incision is maked including the entire sinus opening and an excision of PS was performed without entering the sinus cavity, removing a minimal amount of subcutaneous tissue. Afterwards the highly concentrated fibrin glue, containing 1,000 U/ml of thrombin was applied to cover the wound. Post-operative pain, analgesic consumption, duration of hospital stay, failure healing, the rate and time of recurrence, time to healing, time to return to work and post-operative complications were recordered.
All patients expressed satisfaction with the procedure. Mean hospital stay was 5.4 +/- 2.1 hours. Healing was achieved after 25.8 +/- 13.2 days. The post-operative pain mean score was 3.8 +/- 2.1 in first day, 2,9 +/- 1,8 in third day and 1,3 +/- 0,8 in the seventh day. The mean analgesic consumption per week was 5,6 +/- 3,2 medications. Mean time to return to work was 5,3 +/- 2,1 days.
The minimal excision of PS and application of fibrin glue is a non-invasive effective treatment, easy and simple to performe and not associated to recurrences. For these reasons this procedure in our opinion as the first line treatment for pilonidal sinus disease.
骶尾部藏毛窦(PS)疾病是一种后天性疾病,由脱落的毛干穿透皮肤引起。文献中描述了不同类型的手术。最近,纤维蛋白胶已成功应用。本研究的目的是评估纤维蛋白胶治疗藏毛窦的有效性。
本研究纳入了8例年龄在21.8±6.5岁的骶尾部PS疾病患者。所有患者均在局部麻醉下接受手术。通过主开口注入1%亚甲蓝后,做一个小的垂直椭圆形切口,包括整个窦口,在不进入窦腔的情况下切除PS,切除少量皮下组织。然后应用含有1000 U/ml凝血酶的高浓度纤维蛋白胶覆盖伤口。记录术后疼痛、镇痛药物用量、住院时间、愈合失败情况、复发率和复发时间、愈合时间、恢复工作时间及术后并发症。
所有患者对该手术表示满意。平均住院时间为5.4±2.1小时。25.8±13.2天后实现愈合。术后第1天疼痛平均评分为3.8±2.1,第3天为2.9±1.8,第7天为1.3±0.8。每周平均镇痛药物用量为5.6±3.2剂。平均恢复工作时间为5.3±2.1天。
PS的最小化切除及纤维蛋白胶的应用是一种非侵入性的有效治疗方法,操作简单易行,且无复发。基于这些原因,我们认为该手术是藏毛窦疾病的一线治疗方法。